Perioperative brachytherapy as an additional therapeutic option in patients with renal cell carcinoma (RCC), either inoperable or after completed percutaneous radiotherapy.
Between January 1992 and December 1997 60 patients with different tumors were treated with perioperative high dose rate brachytherapy with Iridium 192 in afterloading technique (HDR), total dosis 20-30 Gy. Three of the patients had RCC. These patients are presented in detail. In elected patients in whom other forms of treatment are not available or have failed, the method offers an additional therapeutic option and can achieve excellent results.
Kwiatkowski
J
J
Radiologische Klinik, Katharinenhospital Stuttgart, Germany.
Schmidt
B
B
Merkle
P
P
Keller
K
K
D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery* / Q000628:therapy; D008875:Middle Aged; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage
D016898:Interferon-alpha; D007496:Iridium Radioisotopes